BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008;99:1210-1215. [PMID: 18813312 DOI: 10.1038/sj.bjc.6604527] [Cited by in Crossref: 144] [Cited by in F6Publishing: 120] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Ronsini C, Foresta A, Giudice M, Reino A, La Verde M, Corte LD, Bifulco G, Franciscis PD, Cianci S, Capozzi VA. Is Adnexectomy Mandatory at the Time of Hysterectomy for Uterine Sarcomas? A Systematic Review and Meta-Analysis. Medicina 2022;58:1140. [DOI: 10.3390/medicina58091140] [Reference Citation Analysis]
2 Yu HY, Jin YL. Metastatic low-grade endometrial stromal sarcoma with variable morphologies in the ovaries and mesentery: A case report. World J Clin Cases 2022; 10(23): 8384-8391 [DOI: 10.12998/wjcc.v10.i23.8384] [Reference Citation Analysis]
3 Borella F, Bertero L, Cassoni P, Piovano E, Gallio N, Preti M, Cosma S, Ferraioli D, Pace L, Mariani L, Biglia N, Benedetto C. Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. Front Oncol 2022;12:883344. [DOI: 10.3389/fonc.2022.883344] [Reference Citation Analysis]
4 Meng LL, Jia XP, Lu LX, Zhang HZ, Shen XH, Piao ZH, Ge R, Yu WY. Unusual morphologic features of low-grade endometrial stromal sarcoma: A case report. J Clin Lab Anal 2022;:e24502. [PMID: 35642882 DOI: 10.1002/jcla.24502] [Reference Citation Analysis]
5 Smith ES, Jansen C, Miller KM, Chiang S, Alektiar KM, Hensley ML, Mueller JJ, Abu-Rustum NR, Leitao MM Jr. Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma. Int J Gynecol Cancer 2022:ijgc-2022-003383. [PMID: 35641004 DOI: 10.1136/ijgc-2022-003383] [Reference Citation Analysis]
6 Wolford JE, Ferrigni E, Margul D, Herzog TJ. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers. Curr Oncol Rep. [DOI: 10.1007/s11912-021-01163-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huang Y, Lin Y, Li Y, Chu K, Zhou Y, Lin L, Zhou R, Zhang Z, Lin Q. Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis. Cancer Medicine. [DOI: 10.1002/cam4.4643] [Reference Citation Analysis]
8 Morrison J, Balega J, Buckley L, Clamp A, Crosbie E, Drew Y, Durrant L, Forrest J, Fotopoulou C, Gajjar K, Ganesan R, Gupta J, Hughes J, Miles T, Moss E, Nanthakumar M, Newton C, Ryan N, Walther A, Taylor A. British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice. European Journal of Obstetrics & Gynecology and Reproductive Biology 2022;270:50-89. [DOI: 10.1016/j.ejogrb.2021.11.423] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
9 Lee Y, Bai Y, Chang C, Huang C, Kung F, Yin C. High-grade endometrial stromal sarcoma in cesarean section scar isthmocele - case report. Taiwanese Journal of Obstetrics and Gynecology 2022;61:388-90. [DOI: 10.1016/j.tjog.2022.02.036] [Reference Citation Analysis]
10 Wu Y, Li N, Zhang R, Bai P. Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature. World J Surg Oncol 2022;20:17. [PMID: 35027071 DOI: 10.1186/s12957-021-02474-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sharma A, Bal M, Menon S. Extragenital endometrial stromal sarcoma of transverse mesocolon: A diagnostic conundrum. Int J Surg Pathol 2021;:10668969211070485. [PMID: 34970922 DOI: 10.1177/10668969211070485] [Reference Citation Analysis]
12 Sousa FAE, Ferreira J, Cunha TM. MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation. Abdom Radiol (NY) 2021;46:5687-706. [PMID: 34468798 DOI: 10.1007/s00261-021-03263-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, Ivanova Y, Slavchev S, Mitev D, Yordanov A. New Aspects of Sarcomas of Uterine Corpus-A Brief Narrative Review. Clin Pract 2021;11:878-900. [PMID: 34842646 DOI: 10.3390/clinpract11040103] [Reference Citation Analysis]
14 Akametalu P, Barcelon J, Myint O, Moatamed N, Karlan B, Kamrava M, Cohen J. Vaginal high-grade sarcoma in pregnancy. Gynecologic Oncology Reports 2021;38:100881. [DOI: 10.1016/j.gore.2021.100881] [Reference Citation Analysis]
15 Nath AG, Suchetha S, Rema PN, Sivarenjith J, John ER, Mony RP. Endometrial Stromal Sarcoma, an Unusual Recurrence: A Case Report. J Obstet Gynaecol India 2021;71:448-51. [PMID: 34566308 DOI: 10.1007/s13224-021-01442-9] [Reference Citation Analysis]
16 Tang Y, Chen Y, Tian L, Chen J, Yang P, Zhang D, Cui Q, Zhao L, Li L. Vaginal Low-Grade Endometrial Stromal Sarcoma: An Extremely Rare Case Report and Review of the Literature. Int J Gynecol Pathol 2020;39:447-51. [PMID: 31569185 DOI: 10.1097/PGP.0000000000000626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Akaev I, Yeoh CC, Rahimi S. Update on Endometrial Stromal Tumours of the Uterus. Diagnostics (Basel) 2021;11:429. [PMID: 33802452 DOI: 10.3390/diagnostics11030429] [Reference Citation Analysis]
18 Friedlander M, Benson C, O'Connell RL, Reed N, Clamp A, Lord R, Millan D, Nottley S, Amant F, Steer C, Anand A, Mileshkin L, Beale P, Banerjee S, Bradshaw N, Kelly C, Carty K, Divers L, Alexander L, Edmondson R. Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903). Gynecol Oncol 2021;161:160-5. [PMID: 33608144 DOI: 10.1016/j.ygyno.2021.02.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe 2020;41:621-33. [PMID: 32940744 DOI: 10.1007/s00292-020-00826-4] [Reference Citation Analysis]
20 Fan JK, Tang GC, Yang H. Endometrial stromal sarcoma extending to the pulmonary artery: A rare case report. World J Clin Cases 2020; 8(22): 5625-5631 [PMID: 33344553 DOI: 10.12998/wjcc.v8.i22.5625] [Reference Citation Analysis]
21 Cabrera S, Bebia V, Acosta U, Franco-Camps S, Mañalich L, García-Jiménez A, Gil-Moreno A. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma. Clin Transl Oncol 2021;23:1210-9. [PMID: 33210235 DOI: 10.1007/s12094-020-02512-6] [Reference Citation Analysis]
22 Mindiola-Romero AE, Liu X, Dillon JL, Talarico M, Smith G, Zhang L, Linos K. Metastatic low-grade endometrial stromal sarcoma after 24 years: A case report and review of recent molecular genetics. Diagn Cytopathol 2021;49:E99-E105. [PMID: 32910526 DOI: 10.1002/dc.24601] [Reference Citation Analysis]
23 Wu J, Zhang H, Li L, Hu M, Chen L, Wu S, Xu B, Song Q. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis. Int J Gynecol Cancer 2020;30:1520-7. [PMID: 32839227 DOI: 10.1136/ijgc-2020-001409] [Reference Citation Analysis]
24 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond) 2020;40:301-12. [PMID: 32558385 DOI: 10.1002/cac2.12067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Purbadi S, Saspriyana KY. Recurrent endometrial stromal sarcoma in the abdominal wall following a total hysterectomy: A rare case report. Int J Surg Case Rep 2020;68:242-5. [PMID: 32197223 DOI: 10.1016/j.ijscr.2020.03.003] [Reference Citation Analysis]
27 Zhang Y, Li N, Wang W, Yao H, An J, Li N, Sun Y, Wu L. Long-term impact of lymphadenectomies in patients with low-grade, early-stage uterine endometrial stroma sarcoma. J Obstet Gynaecol Res 2020;46:654-62. [PMID: 32022392 DOI: 10.1111/jog.14198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Nasioudis D, Ko EM, Kolovos G, Vagios S, Kalliouris D, Giuntoli RL. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis. Int J Gynecol Cancer 2019;29:126-32. [PMID: 30640694 DOI: 10.1136/ijgc-2018-000063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Sohail R, Kanwal S, Murtaza A, Haq B. Endometrial stromal sarcoma in a 20-year-old woman. BMJ Case Rep 2019;12:e228874. [PMID: 31818885 DOI: 10.1136/bcr-2018-228874] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 2019;79:1043-60. [PMID: 31656317 DOI: 10.1055/a-0882-4116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ludovisi M, Moro F, Pasciuto T, Di Noi S, Giunchi S, Savelli L, Pascual MA, Sladkevicius P, Alcazar JL, Franchi D, Mancari R, Moruzzi MC, Jurkovic D, Chiappa V, Guerriero S, Exacoustos C, Epstein E, Frühauf F, Fischerova D, Fruscio R, Ciccarone F, Zannoni GF, Scambia G, Valentin L, Testa AC. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound Obstet Gynecol 2019;54:676-87. [DOI: 10.1002/uog.20270] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
32 Zhang Y, Li Y, Huang H, Yang J, Wu M, Jin Y, Pan L. Low-Grade Endometrial Stromal Sarcoma and Uterine Adenosarcoma: A Comparison of Clinical Manifestations and Outcomes. J Cancer 2019;10:3352-60. [PMID: 31293638 DOI: 10.7150/jca.30691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Comert GK, Turkmen O, Kar I, Yucel O, Kilic C, Boran N, Basaran D, Karalok A, Turan T. Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate? J Chin Med Assoc 2019;82:385-9. [PMID: 31058712 DOI: 10.1097/JCMA.0000000000000039] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Park NC, Han SJ, Lee JW, Choi HJ, Kim EJ, Jung MH, Jang JB, Hwang DS, Kim KS. Apoptotic effect of Gyejibokryunghwan on uterine sarcoma cells (SK-UT-1B). Phytomedicine 2019;61:152806. [PMID: 31035046 DOI: 10.1016/j.phymed.2018.12.029] [Reference Citation Analysis]
35 Dickson BC. Beyond Smooth Muscle-Other Mesenchymal Neoplasms of the Uterus. Surg Pathol Clin 2019;12:107-37. [PMID: 30709439 DOI: 10.1016/j.path.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Zhang YY, Li Y, Qin M, Cai Y, Jin Y, Pan LY. High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis. Cancer Manag Res. 2019;11:831-837. [PMID: 30697075 DOI: 10.2147/cmar.s187849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
37 Mbatani N, Olawaiye AB, Prat J. Uterine sarcomas. Int J Gynaecol Obstet. 2018;143 Suppl 2:51-58. [PMID: 30306577 DOI: 10.1002/ijgo.12613] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
38 Barquet-Muñoz SA, Isla-Ortiz D, Montalvo-Esquivel G, Cantú-de-León D, Salcedo-Hernández RA, Cordoba-Gonzalez V, Herrera-Gómez Á. Prognostic factors associated with uterine sarcomas: the experience of a single institution. J Obstet Gynaecol 2019;39:231-6. [PMID: 30354797 DOI: 10.1080/01443615.2018.1492529] [Reference Citation Analysis]
39 Thiel FC, Halmen S. Low-Grade Endometrial Stromal Sarcoma - a Review. Oncol Res Treat. 2018;41:687-692. [PMID: 30317238 DOI: 10.1159/000494225] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
40 Chin TH, Lin G, Wu RC, Lai CH. Recurrence after fertility-preserving surgery for low-grade endometrial stromal sarcoma. J Obstet Gynaecol Res 2018;44:1836-42. [PMID: 29974555 DOI: 10.1111/jog.13695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Michael Straughn J Jr, Boitano T, Smith HJ, Dilley SE, Liang MI, Novak L. Treatment of low-grade endometrial stromal sarcoma in a nulligravid woman. Gynecol Oncol 2018;151:6-9. [PMID: 29887484 DOI: 10.1016/j.ygyno.2018.05.027] [Reference Citation Analysis]
42 Deshmukh U, Black J, Perez-irizarry J, Passarelli R, Levy K, Rostkowski A, Hui P, Rutherford TJ, Santin AD, Azodi M, Silasi D, Ratner E, Litkouhi B, Schwartz PE. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma. Reprod Sci 2018;26:600-8. [DOI: 10.1177/1933719118778801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
43 Sardi A, Muñoz-Zuluaga CA, Sittig M, Diaz-Montes T. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma. Clin Case Rep 2018;6:1142-52. [PMID: 29881584 DOI: 10.1002/ccr3.1491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
44 Stewart L, Beck T, Giannakopoulos N, Rendi M, Isacson C, Goff B. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review. Gynecologic Oncology 2018;149:297-300. [DOI: 10.1016/j.ygyno.2018.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
45 Xie W, Cao D, Yang J, Jiang X, Shen K, Pan L, Huang H, Lang J, You Y, Chen J. Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma. Oncotarget. 2017;8:10602-10608. [PMID: 27736798 DOI: 10.18632/oncotarget.12491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
46 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 12.8] [Reference Citation Analysis]
47 Verschoor AJ, Warmerdam FARM, Bosse T, Bovée JVMG, Gelderblom H. A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report. BMC Cancer 2018;18:92. [PMID: 29357824 DOI: 10.1186/s12885-018-3999-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
48 Halaska MJ, Haidopoulos D, Guyon F, Morice P, Zapardiel I, Kesic V; ESGO Council. European Society of Gynecological Oncology Statement on Fibroid and Uterine Morcellation. Int J Gynecol Cancer 2017;27:189-92. [PMID: 28002210 DOI: 10.1097/IGC.0000000000000911] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
49 Xiu XX, Wang HL, Yun-Yi L, Fan-Dou K, Jin-Ping H. Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review. Medicine (Baltimore) 2017;96:e8928. [PMID: 29245257 DOI: 10.1097/MD.0000000000008928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Desar IME, Ottevanger PB, Benson C, van der Graaf WTA. Systemic treatment in adult uterine sarcomas. Crit Rev Oncol Hematol. 2018;122:10-20. [PMID: 29458779 DOI: 10.1016/j.critrevonc.2017.12.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
51 Wong M, De Wilde RL, Isaacson K. Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery. Arch Gynecol Obstet 2018;297:285-93. [PMID: 29128980 DOI: 10.1007/s00404-017-4575-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
52 Agarwal R, Rajanbabu A, Nair IR, Satish C, Jose G, Unikrishnan U. Endometrial stromal sarcoma—A retropsective analysis of factors affecting recurrence. European Journal of Obstetrics & Gynecology and Reproductive Biology 2017;216:92-7. [DOI: 10.1016/j.ejogrb.2017.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
53 Roy M, Kumar S, Bhatla N, Ray MD, Kumar L, Jain D, Phulware R, Mathur SR. Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features. International Journal of Gynecological Pathology 2017;36:420-7. [DOI: 10.1097/pgp.0000000000000353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
54 Seagle BL, Shilpi A, Buchanan S, Goodman C, Shahabi S. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Gynecol Oncol. 2017;146:254-262. [PMID: 28596015 DOI: 10.1016/j.ygyno.2017.05.036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
55 Cui R, Yuan F, Wang Y, Li X, Zhang Z, Bai H. Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma. Medicine (Baltimore). 2017;96:e6584. [PMID: 28403089 DOI: 10.1097/md.0000000000006584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
56 Horng HC, Wen KC, Wang PH, Chen YJ, Yen MS, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Taiwan J Obstet Gynecol. 2016;55:472-479. [PMID: 27590366 DOI: 10.1016/j.tjog.2016.04.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
57 Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, Gallos I, Ganesan R, Gupta J, Johnson N, Kitson S, Mackintosh M, Martin-Hirsch P, Miles T, Rafii S, Reed N, Rolland P, Singh K, Sivalingam V, Walther A. BGCS uterine cancer guidelines: Recommendations for practice. Eur J Obstet Gynecol Reprod Biol 2017;213:71-97. [PMID: 28437632 DOI: 10.1016/j.ejogrb.2017.04.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
58 Allen AJ, Ali SM, Gowen K, Elvin JA, Pejovic T. A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1. Gynecol Oncol Rep 2017;20:51-3. [PMID: 28331900 DOI: 10.1016/j.gore.2017.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
59 Liu H, Zhu Y, Zhang GN, Wang C, Li C, Shi Y. Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis. Sci Rep 2016;6:31229. [PMID: 27503773 DOI: 10.1038/srep31229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Prat J, Mbatani N. Uterine sarcomas. Int J Gynaecol Obstet. 2015;131 Suppl 2:S105-S110. [PMID: 26433666 DOI: 10.1016/j.ijgo.2015.06.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
61 Zhang J, Li T, Zhang J, Zhu L, Lang J, Leng J. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation: . International Journal of Gynecological Cancer 2016;26:456-63. [DOI: 10.1097/igc.0000000000000638] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
62 Srettabunjong S, Chuangsuwanich T. Inferior Vena Cava Tumor Thrombosis Secondary to Metastatic Uterine Cancer: A Rare Cause of Sudden Unexpected Death. J Forensic Sci 2016;61:555-8. [PMID: 27404631 DOI: 10.1111/1556-4029.13032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
63 Si M, Jia L, Song K, Zhang Q, Kong B. Role of Lymphadenectomy for Uterine Sarcoma: A Meta-Analysis. Int J Gynecol Cancer 2016;27:109-16. [DOI: 10.1097/igc.0000000000000842] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
64 Burghaus S, Halmen S, Gass P, Mehlhorn G, Schrauder MG, Lux MP, Renner SP, Beckmann MW, Hein A, Thiel FC. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor. Arch Gynecol Obstet 2016;294:343-51. [PMID: 26711836 DOI: 10.1007/s00404-015-3993-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
65 Cho H, Kim K, Kim Y, No JH. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics: Uterine sarcoma: Preoperative indicators. J Obstet Gynaecol Res 2016;42:313-8. [DOI: 10.1111/jog.12915] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
66 Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, Ulrich U, Horn LC, Schmidt D, Vordermark D, Vogl T, Reichardt P, Gaß P, Gebhardt M, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015;75:1028-42. [PMID: 26640293 DOI: 10.1055/s-0035-1558120] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
67 Zhou J, Zheng H, Wu SG, He ZY, Li FY, Su GQ, Sun JY. Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study. Int J Surg. 2015;23:147-151. [PMID: 26449652 DOI: 10.1016/j.ijsu.2015.09.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
68 Laurelli G, Falcone F, Scaffa C, Messalli EM, Del Giudice M, Losito S, Greggi S. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2015;195:61-66. [PMID: 26476800 DOI: 10.1016/j.ejogrb.2015.09.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
69 Park GE, Rha SE, Oh SN, Lee A, Lee KH, Kim MR. Ultrasonographic findings of low-grade endometrial stromal sarcoma of the uterus with a focus on cystic degeneration. Ultrasonography 2016;35:124-30. [PMID: 26537303 DOI: 10.14366/usg.15045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
70 Roma AA, Barbuto DA, Samimi SA, Stolnicu S, Alvarado-Cabrero I, Chanona-Vilchis J, Aguilera-Barrantes I, de Peralta-Venturina M, Malpica A, Rutgers JK, Silva EG. Vascular invasion in uterine sarcomas and its significance. A multi-institutional study. Hum Pathol 2015;46:1712-21. [PMID: 26410057 DOI: 10.1016/j.humpath.2015.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
71 Chow LT. Delayed osseous metastasis from low-grade endometrial stromal sarcoma: Uncommon occurrence deserving recognition. J Obstet Gynaecol Res 2015;41:1669-75. [PMID: 26171849 DOI: 10.1111/jog.12766] [Reference Citation Analysis]
72 Pautier P, Nam EJ, Provencher DM, Hamilton AL, Mangili G, Siddiqui NA, Westermann AM, Reed NS, Harter P, Ray-Coquard I. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus. Int J Gynecol Cancer. 2014;24:S73-S77. [PMID: 25341584 DOI: 10.1097/igc.0000000000000281] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 5.6] [Reference Citation Analysis]
73 Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B. Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. Int J Gynecol Cancer 2014;24:S67-72. [PMID: 25033257 DOI: 10.1097/IGC.0000000000000205] [Cited by in Crossref: 50] [Cited by in F6Publishing: 16] [Article Influence: 7.1] [Reference Citation Analysis]
74 Liu FW, Galvan-Turner VB, Pfaendler KS, Longoria TC, Bristow RE. A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature. Am J Obstet Gynecol 2015;212:717-24. [PMID: 25582101 DOI: 10.1016/j.ajog.2015.01.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
75 Amant F, Lorusso D, Mustea A, Duffaud F, Pautier P. Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin. Sarcoma 2015;2015:704124. [PMID: 26089739 DOI: 10.1155/2015/704124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
76 Yamazaki H, Todo Y, Mitsube K, Hareyama H, Shimada C, Kato H, Yamashiro K. Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study. J Gynecol Oncol 2015;26:214-21. [PMID: 25925291 DOI: 10.3802/jgo.2015.26.3.214] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
77 Zhang J, Zhang J, Dai Y, Zhu L, Lang J, Leng J. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy. International Journal of Gynecology & Obstetrics 2015;130:195-9. [DOI: 10.1016/j.ijgo.2015.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
78 Ebner F, Friedl TWP, Scholz C, Schochter F, Janni W, Vorwerk E, deGregorio N. Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques. Arch Gynecol Obstet 2015;292:499-506. [DOI: 10.1007/s00404-015-3664-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
79 Lee C, Nucci MR. Endometrial stromal sarcoma - the new genetic paradigm. Histopathology 2015;67:1-19. [DOI: 10.1111/his.12594] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 8.9] [Reference Citation Analysis]
80 He L, Li JD, Xiong Y, Huang X, Huang L, Lin JX, Zhou Y, Zheng M. Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China. Arch Gynecol Obstet 2014;289:383-91. [PMID: 23959089 DOI: 10.1007/s00404-013-2987-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
81 Noventa M, Gizzo S, Conte L, Dalla Toffola A, Litta P, Saccardi C. Fertility sparing surgery in young women affected by endometrial stromal sarcoma: an oncologic dilemma or a reliable option? Onco Targets Ther. 2015;8:29-35. [PMID: 25565863 DOI: 10.2147/ott.s69507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
82 Chow LT. Osteosarcoma arising from metastatic low grade endometrial stromal sarcoma. Pathology 2015;47:75-8. [PMID: 25474520 DOI: 10.1097/PAT.0000000000000198] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Kruse A, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK. Aggressive Behavior and Poor Prognosis of Endometrial Stromal Sarcomas With YWHAE-FAM22 Rearrangement Indicate the Clinical Importance to Recognize This Subset: . International Journal of Gynecological Cancer 2014;24:1616-22. [DOI: 10.1097/igc.0000000000000278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
84 Cade TJ, Quinn MA, Rome RM, Polyakov A. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma. Aust N Z J Obstet Gynaecol 2014;54:453-6. [DOI: 10.1111/ajo.12245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
85 Gremel G, Liew M, Hamzei F, Hardell E, Selling J, Ghaderi M, Stemme S, Pontén F, Carlson JW. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival. Int J Cancer 2015;136:1608-18. [PMID: 25130488 DOI: 10.1002/ijc.29141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
86 Philip C, Pautier P, Duffaud F, Ray-coquard I. High-Grade Undifferentiated Sarcomas of the Uterus: Diagnosis, Outcomes, and New Treatment Approaches. Curr Oncol Rep 2014;16. [DOI: 10.1007/s11912-014-0405-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
87 Hrzenjak A, Dieber-Rotheneder M, Moinfar F, Petru E, Zatloukal K. Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategies. Cancer Lett 2014;354:21-7. [PMID: 25128649 DOI: 10.1016/j.canlet.2014.08.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
88 Martin-Liberal J, Benson C, Messiou C, Fisher C, Judson I. Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma. Case Rep Med 2014;2014:612496. [PMID: 25104960 DOI: 10.1155/2014/612496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
89 Rothmund R, Hartkopf A, Joachim C, Walter CB, Wallwiener M, Kraemer B, Brucker SY, Staebler A, Taran FA. Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors. Arch Gynecol Obstet 2014;290:1195-200. [DOI: 10.1007/s00404-014-3320-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
90 El-Khalfaoui K, du Bois A, Heitz F, Kurzeder C, Sehouli J, Harter P. Current and future options in the management and treatment of uterine sarcoma. Ther Adv Med Oncol 2014;6:21-8. [PMID: 24381658 DOI: 10.1177/1758834013513314] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
91 Harter P, El-Khalfaoui K, Heitz F, du Bois A. Operative and Conservative Treatment of Uterine Sarcomas. Geburtshilfe Frauenheilkd 2014;74:267-70. [PMID: 24882876 DOI: 10.1055/s-0034-1368204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
92 Yim GW, Nam EJ, Kim SW, Kim YT. FIGO staging for uterine sarcomas: can the revised 2008 staging system predict survival outcome better? Yonsei Med J 2014;55:563-9. [PMID: 24719120 DOI: 10.3349/ymj.2014.55.3.563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
93 Thanopoulou E, Judson I. Hormonal therapy in gynecological sarcomas. Expert Review of Anticancer Therapy 2014;12:885-94. [DOI: 10.1586/era.12.74] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
94 Bai H, Yang J, Cao D, Huang H, Xiang Y, Wu M, Cui Q, Chen J, Lang J, Shen K. Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases. Gynecol Oncol. 2014;132:654-660. [PMID: 24412112 DOI: 10.1016/j.ygyno.2013.12.032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
95 Yoon A, Park J, Park J, Lee Y, Kim T, Choi CH, Bae D, Kim B, Lee J, Nam J. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases. Gynecologic Oncology 2014;132:70-5. [DOI: 10.1016/j.ygyno.2013.10.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
96 van Kruchten M, Hospers GA, Glaudemans AW, Hollema H, Arts HJ, Reyners AK. Positron emission tomography imaging of oestrogen receptor-expression in endometrial stromal sarcoma supports oestrogen receptor-targeted therapy: Case report and review of the literature. European Journal of Cancer 2013;49:3850-5. [DOI: 10.1016/j.ejca.2013.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
97 Rauh-Hain JA, del Carmen MG. Endometrial stromal sarcoma: a systematic review. Obstet Gynecol. 2013;122:676-683. [PMID: 23921879 DOI: 10.1097/AOG.0b013e3182a189ac] [Cited by in Crossref: 58] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
98 Novetsky AP, Powell MA. Management of sarcomas of the uterus. Current Opinion in Oncology 2013;25:546-52. [DOI: 10.1097/cco.0b013e328363e0ef] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
99 Feng W, Malpica A, Robboy SJ, Gudlaugsson E, Hua K, Zhou X, Baak JPA. Prognostic Value of the Diagnostic Criteria Distinguishing Endometrial Stromal Sarcoma, Low Grade From Undifferentiated Endometrial Sarcoma, 2 Entities Within the Invasive Endometrial Stromal Neoplasia Family: . International Journal of Gynecological Pathology 2013;32:299-306. [DOI: 10.1097/pgp.0b013e318229adfb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
100 Malouf GG, Lhommé C, Duvillard P, Morice P, Haie-Meder C, Pautier P. Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy. Int J Gynaecol Obstet 2013;122:57-61. [PMID: 23597861 DOI: 10.1016/j.ijgo.2013.01.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
101 Sardinha R, Hernández T, Fraile S, Tresserra F, Vidal A, Gómez MC, Astudillo A, Hernández N, Saenz de Santamaría J, Ordi J, Gonçalves L, Ramos R, Balañá C, de Álava E. Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors. Clin Sarcoma Res 2013;3:3. [PMID: 23497641 DOI: 10.1186/2045-3329-3-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
102 Iwasaki S, Sudo T, Miwa M, Ukita M, Morimoto A, Tamada M, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Sakuma Y, Mikami Y, Nishimura R. Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases. Arch Gynecol Obstet 2013;288:385-91. [DOI: 10.1007/s00404-013-2766-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
103 Feng W, Hua K, Gudlaugsson E, Yu Y, Zhou X, Baak JPA. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma: Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma. Histopathology 2013;62:675-87. [DOI: 10.1111/j.1365-2559.2011.04115.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
104 Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG; RARECARE Working Group. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013;49:684-695. [PMID: 23079473 DOI: 10.1016/j.ejca.2012.09.011] [Cited by in Crossref: 284] [Cited by in F6Publishing: 248] [Article Influence: 28.4] [Reference Citation Analysis]
105 Puliyath G, Nair MK. Endometrial stromal sarcoma: A review of the literature. Indian J Med Paediatr Oncol 2012;33:1-6. [PMID: 22754201 DOI: 10.4103/0971-5851.96960] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
106 Shah SH, Jagannathan JP, Krajewski K, O'Regan KN, George S, Ramaiya NH. Uterine sarcomas: then and now. AJR Am J Roentgenol. 2012;199:213-223. [PMID: 22733915 DOI: 10.2214/ajr.11.7287] [Cited by in Crossref: 69] [Cited by in F6Publishing: 20] [Article Influence: 6.9] [Reference Citation Analysis]
107 Jakate K, Azimi F, Ali RH, Lee C, Clarke BA, Rasty G, Shaw PA, Melnyk N, Huntsman DG, Laframboise S, Rouzbahman M. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol 2013;26:95-105. [DOI: 10.1038/modpathol.2012.136] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
108 Tanz R, Mahfoud T, Bazine A, Aassab R, Benjaafar N, El Khalil El Gueddari B, Ichou M, Errihani H. Endometrial stromal sarcoma: prognostic factors and impact of adjuvant therapy in early stages. Hematol Oncol Stem Cell Ther 2012;5:31-5. [PMID: 22446608 DOI: 10.5144/1658-3876.2012.31] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
109 Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol 2012;51:694-705. [PMID: 22793037 DOI: 10.3109/0284186X.2012.689111] [Cited by in Crossref: 102] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
110 Tanner EJ, Garg K, Leitao MM Jr, Soslow RA, Hensley ML. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 2012;127:27-31. [PMID: 22750260 DOI: 10.1016/j.ygyno.2012.06.030] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
111 Lee C, Mariño-enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-rychter M, Dal Cin P, Fletcher JA, Nucci MR. The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor. American Journal of Surgical Pathology 2012;36:641-53. [DOI: 10.1097/pas.0b013e31824a7b1a] [Cited by in Crossref: 170] [Cited by in F6Publishing: 42] [Article Influence: 17.0] [Reference Citation Analysis]
112 Nam J. Surgical treatment of uterine sarcoma. Best Practice & Research Clinical Obstetrics & Gynaecology 2011;25:751-60. [DOI: 10.1016/j.bpobgyn.2011.05.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
113 Gadducci A. Prognostic factors in uterine sarcoma. Best Practice & Research Clinical Obstetrics & Gynaecology 2011;25:783-95. [DOI: 10.1016/j.bpobgyn.2011.06.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
114 Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol. 2011;25:681-689. [PMID: 21816678 DOI: 10.1016/j.bpobgyn.2011.07.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
115 Tse KY, Crawford R, Ngan HY. Staging of uterine sarcomas. Best Pract Res Clin Obstet Gynaecol 2011;25:733-49. [PMID: 21752716 DOI: 10.1016/j.bpobgyn.2011.05.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
116 García-martínez E, Egea Prefasi L, García-donas J, Escolar-pérez PP, Pastor F, González-martín A. Current management of uterine sarcomas. Clin Transl Oncol 2011;13:307-14. [DOI: 10.1007/s12094-011-0659-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
117 Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol. 2011;18:3453-3461. [PMID: 21541824 DOI: 10.1245/s10434-011-1751-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
118 dos Santos LA, Garg K, Diaz JP, Soslow RA, Hensley ML, Alektiar KM, Barakat RR, Leitao MM. Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma. Gynecologic Oncology 2011;121:319-22. [DOI: 10.1016/j.ygyno.2010.12.363] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
119 Gliem M, Panayotopoulos D, Feindt P, Heikaus S, Fleisch MC, Seitz RJ. Cerebellar degeneration as presenting symptom of recurrent endometrial stromal sarcoma with sex-cord elements. Case Rep Neurol 2011;3:54-61. [PMID: 21490714 DOI: 10.1159/000324927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Cheng X, Yang G, Schmeler KM, Coleman RL, Tu X, Liu J, Kavanagh JJ. Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy. Gynecol Oncol. 2011;121:323-327. [PMID: 21277011 DOI: 10.1016/j.ygyno.2010.12.360] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
121 Seddon BM, Davda R. Uterine sarcomas--recent progress and future challenges. Eur J Radiol 2011;78:30-40. [PMID: 21247711 DOI: 10.1016/j.ejrad.2010.12.057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
122 Batista LM, Carvalho CH, Acioly MA, Gharabaghi A, Ramina KF, Schittenhelm J, Tatagiba M. Spinal metastasis of endometrial stromal sarcoma: clinicopathological features and management. Surg Oncol 2011;20:e78-83. [PMID: 21071207 DOI: 10.1016/j.suronc.2010.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
123 Della Badia C, Karini H. Endometrial Stromal Sarcoma Diagnosed after Uterine Morcellation in Laparoscopic Supracervical Hysterectomy. Journal of Minimally Invasive Gynecology 2010;17:791-3. [DOI: 10.1016/j.jmig.2010.07.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
124 Dupont NC, Disaia PJ. Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist. Sarcoma 2010;2010:353679. [PMID: 20613993 DOI: 10.1155/2010/353679] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
125 Malouf GG, Duclos J, Rey A, Duvillard P, Lazar V, Haie-Meder C, Balleyguier C, Morice P, Lhommé C, Pautier P. Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma. Ann Oncol 2010;21:2102-6. [PMID: 20305035 DOI: 10.1093/annonc/mdq064] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
126 Chew I, Oliva E. Endometrial stromal sarcomas: a review of potential prognostic factors. Adv Anat Pathol 2010;17:113-21. [PMID: 20179433 DOI: 10.1097/PAP.0b013e3181cfb7c2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
127 Nam J, Park J. Update on treatment of uterine sarcoma. Current Opinion in Obstetrics & Gynecology 2010;22:36-42. [DOI: 10.1097/gco.0b013e328334d90f] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
128 Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10:1188-1198. [PMID: 19959075 DOI: 10.1016/s1470-2045(09)70226-8] [Cited by in Crossref: 250] [Cited by in F6Publishing: 91] [Article Influence: 20.8] [Reference Citation Analysis]
129 Albrektsen G, Heuch I, Wik E, Salvesen HB. Prognostic impact of parity in 493 uterine sarcoma patients. Int J Gynecol Cancer 2009;19:1062-7. [PMID: 19820369 DOI: 10.1111/IGC.0b013e3181aaa950] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
130 Oliva E, Baker PM. Endometrial/ioid Stromal Tumors and Related Neoplasms of the Female Genital Tract. Surgical Pathology Clinics 2009;2:679-705. [DOI: 10.1016/j.path.2009.08.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
131 Yan L, Tian Y, Fu Y, Zhao X. Successful pregnancy after fertility-preserving surgery for endometrial stromal sarcoma. Fertil Steril 2010; 93: 269.e1-269. e3. [PMID: 19880109 DOI: 10.1016/j.fertnstert.2009.09.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
132 D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131-139. [PMID: 19853898 DOI: 10.1016/j.ygyno.2009.09.023] [Cited by in Crossref: 432] [Cited by in F6Publishing: 361] [Article Influence: 33.2] [Reference Citation Analysis]
133 Köhler G. [Uterine sarcoma treatment]. Pathologe 2009;30:304-12. [PMID: 19517111 DOI: 10.1007/s00292-009-1150-3] [Reference Citation Analysis]